Landscape Capital Management L.L.C. grew its stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 131.7% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 37,554 shares of the company’s stock after buying an additional 21,348 shares during the quarter. Landscape Capital Management L.L.C.’s holdings in Acadia Healthcare were worth $1,489,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently bought and sold shares of ACHC. Nisa Investment Advisors LLC boosted its position in Acadia Healthcare by 40.7% in the 4th quarter. Nisa Investment Advisors LLC now owns 1,040 shares of the company’s stock worth $41,000 after purchasing an additional 301 shares in the last quarter. Pacer Advisors Inc. boosted its holdings in Acadia Healthcare by 2.4% during the fourth quarter. Pacer Advisors Inc. now owns 13,847 shares of the company’s stock worth $549,000 after buying an additional 325 shares in the last quarter. Tidal Investments LLC grew its position in Acadia Healthcare by 7.9% during the third quarter. Tidal Investments LLC now owns 4,664 shares of the company’s stock valued at $296,000 after buying an additional 340 shares during the period. Blue Trust Inc. increased its holdings in Acadia Healthcare by 69.4% in the fourth quarter. Blue Trust Inc. now owns 842 shares of the company’s stock valued at $33,000 after buying an additional 345 shares in the last quarter. Finally, Coldstream Capital Management Inc. raised its position in shares of Acadia Healthcare by 7.5% in the third quarter. Coldstream Capital Management Inc. now owns 6,167 shares of the company’s stock worth $391,000 after acquiring an additional 430 shares during the period.
Analyst Upgrades and Downgrades
Several equities analysts recently weighed in on the company. KeyCorp cut their price target on Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Monday, March 3rd. Mizuho reduced their target price on Acadia Healthcare from $48.00 to $37.00 and set a “neutral” rating for the company in a research note on Tuesday, March 25th. Barclays cut shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and dropped their price target for the company from $43.00 to $35.00 in a research note on Friday, February 28th. Deutsche Bank Aktiengesellschaft upgraded shares of Acadia Healthcare from a “hold” rating to a “buy” rating and upped their price objective for the stock from $45.00 to $75.00 in a research report on Thursday, December 12th. Finally, StockNews.com cut shares of Acadia Healthcare from a “hold” rating to a “sell” rating in a research note on Monday, January 6th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the company. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of “Hold” and a consensus target price of $52.19.
Acadia Healthcare Stock Performance
ACHC opened at $27.37 on Friday. The firm has a market capitalization of $2.54 billion, a PE ratio of 8.97, a PEG ratio of 1.46 and a beta of 1.38. The company has a current ratio of 1.07, a quick ratio of 1.07 and a debt-to-equity ratio of 0.60. Acadia Healthcare Company, Inc. has a twelve month low of $26.72 and a twelve month high of $82.41. The firm’s 50-day moving average price is $35.62 and its 200 day moving average price is $43.59.
Acadia Healthcare Profile
Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.
Featured Articles
- Five stocks we like better than Acadia Healthcare
- The Significance of Brokerage Rankings in Stock Selection
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- What Are Dividends? Buy the Best Dividend Stocks
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 3 Fintech Stocks With Good 2021 Prospects
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report).
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.